Author: Billa, Ramya; Tigges, Cody; Vijayakumar, Niranjan; Radke, Joshua; Pedati, Caitlin; Weiner, Rebecca; McCabe, Daniel
Title: E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis Cord-id: dvdo9ivo Document date: 2020_3_19
ID: dvdo9ivo
Snippet: INTRODUCTION: E-cigarette, or vaping, product use associated lung injury (EVALI) has become a recent concern among public health officials. Factors that contribute to the concern include an increasing number of cases over time, the severity of the illness, and an unknown understanding of the pathophysiology and etiology of the illness. CASE SERIES: We cared for three adolescent patients with acute respiratory failure secondary to EVALI. All three patients were treated with high-dose steroids in
Document: INTRODUCTION: E-cigarette, or vaping, product use associated lung injury (EVALI) has become a recent concern among public health officials. Factors that contribute to the concern include an increasing number of cases over time, the severity of the illness, and an unknown understanding of the pathophysiology and etiology of the illness. CASE SERIES: We cared for three adolescent patients with acute respiratory failure secondary to EVALI. All three patients were treated with high-dose steroids in addition to antimicrobials, which resulted in clinical improvement and resolution of their respiratory failure. Pulmonary function testing was performed on these previously healthy patients both acutely and subacutely. Additionally, we report the results from the laboratory analysis of one vaping device fluid which revealed previously unpublished components within these products. DISCUSSION: EVALI is a recent public health concern without a known etiology which can cause life-threatening lung injury in patients without prior lung pathology. We hope these cases will highlight the importance of return precautions in adolescents with vague respiratory symptoms and provide a cautionary tale to providers while they counsel patients regarding the use of these products.
Search related documents:
Co phrase search for related documents- action mechanism and acute exposure: 1, 2
- action mechanism and acute illness: 1, 2, 3, 4, 5, 6
- action mechanism and acute toxicity: 1
- action mechanism and admission day: 1, 2
- action mechanism and loq quantification: 1
- acute ards respiratory distress syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and local hospital: 1, 2, 3, 4
- acute ards respiratory distress syndrome and local hospital admission: 1
- acute exposure and admission prior: 1
- acute illness and admission day: 1, 2, 3, 4, 5, 6, 7, 8
- acute illness and admission prior: 1, 2, 3, 4, 5, 6
- acute illness and local hospital: 1, 2, 3
- acute toxicity and admission day: 1
- admission day and local hospital: 1, 2
- admission day and local hospital admission: 1
- adolescent patient and local emergency department: 1
Co phrase search for related documents, hyperlinks ordered by date